000			02205 a2200625 4500
005			20250515015538.0
264		0	_c20060425
008			200604s 0 0 eng d
022			_a0008-543X
024	7		_a10.1002/cncr.21776 _2doi
040			_aNLM _beng _cNLM
100	1		_aThomas, Deborah A
245	0	0	_aChemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. _h[electronic resource]
260			_bCancer _cApr 2006
300			_a1569-80 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBurkitt Lymphoma _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunotherapy
650	0	4	_aInfusions, Intravenous
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aRituximab
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xadministration & dosage
700	1		_aFaderl, Stefan
700	1		_aO'Brien, Susan
700	1		_aBueso-Ramos, Carlos
700	1		_aCortes, Jorge
700	1		_aGarcia-Manero, Guillermo
700	1		_aGiles, Francis J
700	1		_aVerstovsek, Srdan
700	1		_aWierda, William G
700	1		_aPierce, Sherry A
700	1		_aShan, Jianqin
700	1		_aBrandt, Mark
700	1		_aHagemeister, Fredrick B
700	1		_aKeating, Michael J
700	1		_aCabanillas, Fernando
700	1		_aKantarjian, Hagop
773	0		_tCancer _gvol. 106 _gno. 7 _gp. 1569-80
856	4	0	_uhttps://doi.org/10.1002/cncr.21776 _zAvailable from publisher's website
999			_c16113087 _d16113087